Show
Sort by
-
- Journal Article
- A1
- open access
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C
-
Human genetic and immunological determinants of critical COVID-19 pneumonia
-
- Journal Article
- A1
- open access
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
-
- Journal Article
- A1
- open access
Distinct antibody repertoires against endemic human coronaviruses in children and adults
-
Harnessing type I IFN immunity against SARS-CoV-2 with early administration of IFN-β
-
- Journal Article
- A1
- open access
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19
-
- Journal Article
- A1
- open access
SARS-CoV-2–related MIS-C : a key to the viral and genetic causes of Kawasaki disease?
-
- Journal Article
- A1
- open access
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
-
- Journal Article
- A1
- open access
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
-
- Journal Article
- A1
- open access
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19